Angela S. P. Lin

Angela S. P. Lin

Auto-generated profile, based on publicly available information

Angela S. P. Lin

University of Oregon

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2021 in Acta Biomaterialia
Verified
Journal Article
Closed access
RSRamesh Subbiah
Ramesh Subbiah
MRMarissa A. Ruehle
Marissa A. Ruehle
BKBrett S. Klosterhoff
Brett S. Klosterhoff
ALAngela S.P. Lin
Angela S.P. Lin
MHMarian H. Hettiaratchi
Marian H. Hettiaratchi
RGRobert E Guldberg
Robert E Guldberg

1 April 2021 in Journal of the Mechanical Behavior of Biomedical Materials
Verified
Journal Article
Open access
CKCambre N. Kelly
Cambre N. Kelly
ALAngela Sp. Lin
Angela Sp. Lin
KLKelly Eh. Leguineche
Kelly Eh. Leguineche
SSSudhanshu Shekhar
Sudhanshu Shekhar
WWWilliam R. Walsh
William R. Walsh
KGKen Gall
Ken Gall
Despite the innate ability for bone to remodel and repair, its regeneration has a limit. In these cases of critically sized bone defects (CSBD), the bone deficit must be repaired using reconstructive techniques that support immediate load bearing and encourage bone bridging across the defect. High-strength porous titanium implants offer a solution for treatment of CSBD in which the scaffold can support physiological loads, provide a matrix to guide ingrowth, and carry graft materials and/or biologics. Fabrication of titanium meta-materials via additive manufacturing (AM) has unlocked the potential to modulate mechanical and biological performance to achieve a combination of properties previously unachievable. Meta-material scaffolds with topology based on triply periodic minimal surfaces (TPMS) have gained increasing interest for use in biomedical applications due to their bioinspired nature. Despite enthusiasm for TPMS-based titanium scaffolds due to their high strength to stiffness ratio, high permeability, and curvature similar to trabecular bone, there is little preclinical evidence to support their in vivo response in bone. The present study sought to evaluate the performance of gyroid-sheet titanium scaffolds produced via AM to repair a critically size femoral cortical bone defect in rats. Empty gyroid-sheet scaffolds were shown to repair segmental defects with up to 38% of torsional strength and 54% torsional stiffness of the intact femur (control) at 12-weeks. Gyroid-sheet scaffolds carrying recombinant bone morphogenic protein-2 demonstrated bridging bone growth across the length of the defect, with torsional strength and stiffness superior to that of the intact controls.

1 September 2016 in Journal of the Mechanical Behavior of Biomedical Materials
Verified
Journal Article
Closed access
DSDavid L. Safranski
David L. Safranski
JBJennifer M. Boothby
Jennifer M. Boothby
CKCambre N. Kelly
Cambre N. Kelly
KBKyle Beatty
Kyle Beatty
NLNishant Lakhera
Nishant Lakhera
JGJack C. Griffis
Jack C. Griffis

2 November 2019
Verified
Book Chapter
Closed access
PDF file
ALAngela S.P. Lin
Angela S.P. Lin
SSStuart R. Stock
Stuart R. Stock
RGRobert E Guldberg
Robert E Guldberg

25 September 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
CSClayton M. Small
Clayton M. Small
HHHope M. Healey
Hope M. Healey
MCMark Currey
Mark Currey
EBEmily A. Beck
Emily A. Beck
JCJulian M Catchen
Julian M Catchen
SBSusan Bassham
Susan Bassham
Seadragons are a remarkable lineage of teleost fishes, and they are members of the family Syngnathidae renowned for having evolved male pregnancy. Comprising three known species, seadragons are widely recognized and admired for their fantastical body forms and coloration, and their specific habitat requirements have made them flagship representatives for marine conservation and natural history interests. Until recently, a gap has been the lack of significant genomic resources for seadragons. We have produced gene-annotated, chromosome-scale genome models for the leafy and weedy seadragon to advance investigations into evolutionary innovation and elaboration of morphological traits in seadragons as well as their pipefish and seahorse relatives. We identified several interesting features specific to seadragon genomes, including divergent non-coding regions near a developmental gene important for integumentary outgrowth, a high genome-wide density of repetitive DNA, and recent expansions of transposable elements and a vesicular trafficking gene family. Surprisingly, comparative analyses leveraging the seadragon genomes and additional syngnathid and outgroup genomes revealed striking, syngnathid-specific losses in the family of fibroblast growth factors (FGFs), which likely involve re-organization of highly conserved gene regulatory networks in ways that have not previously been documented in natural populations. The resources presented here serve as important tools for future evolutionary studies of developmental processes in syngnathids and will be a key resource for conservation studies of the extravagant seadragons and their relatives.

1 January 2020 in SSRN Electronic Journal
Verified
Preprint
Open access
PDF file
RSRamesh Subbiah
Ramesh Subbiah
MRMarissa Ruehle
Marissa Ruehle
BKBrett S. Klosterhoff
Brett S. Klosterhoff
ALAngela Sp Lin
Angela Sp Lin
MHMarian H. Hettiaratchi
Marian H. Hettiaratchi
RGRobert E Guldberg
Robert E Guldberg
Type III fractures typically involve segmental bone loss with extensive adjacent soft tissue injury to muscle and vasculature. Such severe composite injuries to bone and muscle often require multiple treatment procedures and are associated with significantly higher rates of complications, including non-union, infection, prolonged disability, and amputation. Successful bone healing depends on early re-vascularization to restore oxygen, nutrient, growth factor, and progenitor cell supply to the injury. Therapeutic angiogenesis strategies have therefore been investigated to promote re-vascularization following severe bone injuries, however results have been inconsistent. In this study, co-stimulation of microvascular fragment constructs with vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF) promoted vascular network formation in vitro compared to VEGF or PDGF alone. In an in vivo model of segmental bone and volumetric muscle loss injury, combined delivery of VEGF and PDGF with a low dose of bone morphogenetic protein-2 (BMP-2) significantly enhanced regeneration of vascularized bone compared to BMP-2 treatment alone. This study demonstrates the potential for a combined osteoinductive and angiogenic growth factor delivery strategy to promote functional bone regeneration following severe composite musculoskeletal injury.